Detalhe da pesquisa
1.
The prognostic value of immune-nutritional status in metastatic colorectal cancer: Prognostic Nutritional Index (PNI).
Support Care Cancer
; 32(6): 374, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777931
2.
The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls.
Support Care Cancer
; 32(2): 119, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252310
3.
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Int J Clin Oncol
; 29(3): 258-265, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310597
4.
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 136, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765293
5.
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?
Curr Treat Options Oncol
; 24(9): 1103-1119, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314645
6.
The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index.
Future Oncol
; 2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185034
7.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133230
8.
CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma.
Prostate
; 82(16): 1564-1571, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031743
9.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol
; 18(23): 2573-2582, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734870
10.
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 192, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849943
11.
Antibody-Drug Conjugates in Triple Negative Breast Cancer.
Clin Breast Cancer
; 24(3): 163-174, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341370
12.
Triple Negative Breast Cancers: An Obsolete Entity?
Clin Breast Cancer
; 24(1): 1-6, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016912
13.
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.
J Chemother
; : 1-7, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497444
14.
The role of immune checkpoint inhibition in triple negative breast cancer.
Expert Rev Anticancer Ther
; 23(10): 1095-1106, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771270
15.
The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma.
J Clin Med
; 12(17)2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37685501
16.
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.
Breast
; 70: 56-62, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343321
17.
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
J Cancer Res Clin Oncol
; 149(8): 4141-4148, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048274
18.
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Breast
; 66: 85-88, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208540